Epstein Secrets

w. One is a high-level concept piece on the global healthcare venture fund idea that we prepared to help David introduce the concept to folks around Carlyle. It provides an overview of the market opportunity as we see it, though of course with much less detail around investment strategy and emphases tha

that end I'd be happy to meet with you in Seattle (or elsewhere) if that would be desirable and would facilitate a discussion. Best regards, Ryan Ryan M. Schwarz Managing Director THE CARLYLE GROUP From: Boris Nikolic [mallto: Sent: Friday, March 11, 2011 2:21 AM To: Ryan Schwarz Subject: RE: Materials a

FW: Materials at request of David Rubenstein Date: Tue, 04 Feb 2014 07:51:42 +0000 Attachments: NaviMed_Global_PPM_Draft_4-18-11_pdf PPM from the Carlyle Check out 10 years plus 31 Board of Advisors structure etc very similar. 2.5% fee. Co-investments, parallel funds etc. B From: Ryan Schwarz [ma

o that end • be happy to meet with you in Seattle (or elsewhere) if that would be desirable and would facilitate a discussion. Best regards, Ryan Ryan M. Schwarz Managing Director THE CARLYLE GROUP 1001 Pennsylvania Ave. =. Washington, DC 20004 direct mobile From: Boris Nikolic [mailto: Sent: Friday, Ma

w. One is a high-level concept piece on the global healthcare venture fund idea that we prepared to help David introduce the concept to folks around Carlyle. It provides an overview of the market opportunity as we see it, though of course with much less detail around investment strategy and emphases tha

ity that we are pursuing involving Xigris, the sole approved, on-market drug for severe sepsis. I look forward to seeing you in the morning. Ryan Ryan M. Schwarz Managing Director THE CARLYLE GROUP 1001 Pennsylvania Ave. =. Washington, DC 20004 202-347-2626 202-347-1818 fax 202-729-5334 direct 202-285-